期刊文献+

HDL-C及其亚型与冠心病患者预后关系的相关性研究 被引量:7

A Study on the Relationship between HDL-C Subtypes and Prognosis of Patients with Coronary Heart Disease
原文传递
导出
摘要 目的:探讨高密度脂蛋白胆固醇(HDL-C)及其亚型与冠心病患者预后的关系。方法:选取2012年6月~2015年12月在我院检查的371例疑似冠心病患者为研究对象,其中确诊为冠心病患者274例为观察组,冠状动脉检查正常者97例为对照组。对两组患者的血脂指标进行检测,同时分析各终点事件与血脂各指标之间的相关性,并采用COX回归分析探讨HDL-C及其亚型与冠心病患者预后的关系。结果:与正常组比较,冠心病患者总胆固醇、低密度脂蛋白胆固醇等指标显著升高,而高密度脂蛋白胆固醇及其亚型HDL2-C显著降低。这种改变随冠状动脉病变支数的增加而更加显著。COX回归分析显示HDL2-C亚型与患者心源性死亡的发生风险存在一定的相关性。结论:HDL2-C亚型与冠心病的发生、发展,患者病变程度存在显著的相关性,可以用作对冠心病患者病情程度和终点事件预测的重要参考指标。 Objective: To investigate the relationship between high-density lipoprotein cholesterol(HDL-C) and its subtypes and the prognosis of patients with coronary heart disease. Methods: 371 suspected patients with coronary artery disease checked in our hospital from Jun 2012 to Dec 2015 were involved in this study. Among them, 274 cases of coronary heart disease patients were classified as observation group. Meanwhile, 97 patients with normal coronary artery were selected as control group. The blood lipid indexes of two groups were detected, and the relationship between HDL-C and its subtypes and the prognosis of patients with coronary heart disease was analyzed by COX regression analysis. Results: Compared with the control group, the levels of total cholesterol and low-density lipoprotein cholesterol in observation group were significantly increased, while HDL-cholesterol and its subtype HDL2-C were significantly decreased. This change is more significantly with the increased in the number of coronary lesions. The COX regression analysis showed that the HDL2-C subtypes had a certain correlation with the risk of cardiac death in patients and can be used to predict the risk of a cardiac event. Conclusions: The high density lipoprotein cholesterol subtypes has a significant correlation with the occurrence, development and pathological changes severity of the coronary heart disease. It can be used as an important reference indicator for predicting the extent of disease and the end events of the patients with coronary heart disease.
作者 蒋晓发 邱丽君 周刚 王顺增 陈宝麟 励永康 JIANG Xiao-fa;QIU Li-jun;ZHOU Gang;WANG ghun-zeng;CHEN Bao-lin;LI Yong-kang(Shanghai Fire Corps Hospital,Shanghai,200443,Chin)
出处 《现代生物医学进展》 CAS 2018年第11期2158-2161,2200,共5页 Progress in Modern Biomedicine
关键词 冠心病 预后 高密度脂蛋白胆固醇 亚型 Coronary heart disease Prognosis High Density Lipoprotein Subtypes
  • 相关文献

参考文献5

二级参考文献18

  • 1Stephen J. Nicholls, MBBS, PhD,E. Murat Tuzcu, MD,IIke Sipahi, MD,Adam W. Grasso, MD,Paul Schoenhagen, MD,Tingfei Hu, MS,Kathy Wolski, MPH,Tim Crowe, BS,Milind Y. Desai, MD,Stanley L. Hazen, MD, PhD,Samir R. Kapadia, MD,Steven E. Nissen, MD,李呈亿(译).他汀、高密度脂蛋白胆固醇与冠状动脉粥样硬化消退[J].美国医学会杂志(中文版),2007,26(3):152-160. 被引量:48
  • 2Shepherd J,Kauss R M.Pathophysiology of triglyceride-rich particles[].The American Journal of Cardiology.1991
  • 3Davigon J,Cohn J S.Triglycerides: a risk factor for coronary heart disease[].Atherosclerosis.1996
  • 4Larosa J C.Triglycerides and coronary risk in women and the elderly[].Archives of Internal Medicine.1997
  • 5Stampter M J. Kraass RMO,Ma J,et al.A prospecitve study of triglyceride level.lowdensity lipoprotein particle diameter and risk myocardial infarction[].The Journal of The American Medical Association.1996
  • 6Syvanne M.Lipid and Lipoproteins as coronary risk factors in NIDDM diabets and the heart disease[].The Lancet.1997
  • 7Rallidis LS, Tellis CC, Lekakis J, et al. Lipoprotein- associ- ated phospholipase A (2) bound on high-density lippoprotein is associated with lower risk for cardiac death in stable coronary artery disease patientsL., a 3-year follow-up [J]. J Am Coil Car- diol, 2012, 60 (20): 2053-2060.
  • 8Sbrana F, Puntoni M, Bigazzi F, et al. High density lipopro- tein cholesterol in coronary artery disease, when higher means later [J]. J Atheroscler Thromb, 2013, 20 (1): 23-31.
  • 9Gao F, ZhouYJ, Zhu X, et al. C- reactive protein and the risk of contrast-induced acute kidney injury in patients under- going pereutaneous coronary intervention [J]. Am J Nephrol, 2011, 34 (3) 203-210.
  • 10黄佐贵,李潇华,社国伟.活动平板负荷试验中变时反应与运动耐量差的患者应用阿托品的意义[J].中国基层医药,2008,15(8):1273-1274. 被引量:5

共引文献33

同被引文献62

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部